Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Calliditas Therapeutics AB

Closing information (x1000 NOK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 1,222,616 Less Arrow 759,453 Less Arrow 223,664
Financial expenses 115,839 Less Arrow 35,632 Less Arrow 9,024
Earnings before taxes -462,973 More Arrow -387,273 Less Arrow -500,653
EBITDA -361,106 Less Arrow -386,907 Less Arrow -511,461
Total assets 1,883,474 Less Arrow 1,847,342 Less Arrow 1,423,737
Current assets 1,291,769 More Arrow 1,335,822 Less Arrow 987,678
Current liabilities 412,450 Less Arrow 307,639 Less Arrow 132,090
Equity capital 339,169 More Arrow 724,818 More Arrow 983,298
- share capital 2,414 Less Arrow 2,254 Less Arrow 2,042
Employees (average) 181 Less Arrow 86 Less Arrow 56

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 18.0% More Arrow 39.2% More Arrow 69.1%
Turnover per employee 6,755 More Arrow 8,831 Less Arrow 3,994
Profit as a percentage of turnover -37.9% Less Arrow -51.0% Less Arrow -223.8%
Return on assets (ROA) -18.4% Less Arrow -19.0% Less Arrow -34.5%
Current ratio 313.2% More Arrow 434.2% More Arrow 747.7%
Return on equity (ROE) -136.5% More Arrow -53.4% More Arrow -50.9%
Change turnover 409,274 More Arrow 542,511 Less Arrow 222,812
Change turnover % 50% More Arrow 250% More Arrow 26141%
Chg. No. of employees 95 Less Arrow 30 More Arrow 33
Chg. No. of employees % 110% Less Arrow 54% More Arrow 143%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.